Cargando…

Increased Oxidative Damage Associated with Unfavorable Cytogenetic Subgroups in Chronic Lymphocytic Leukemia

Oxidative stress contributes to genomic instability in chronic lymphocytic leukemia (CLL), but its relationship with the acquisition of specific chromosomal abnormalities is unknown. We recruited 55 untreated CLL patients and assessed 8-oxo-2′-deoxyguanosine (8-oxo-dG), glutathione, and malondialdeh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Collado, Rosa, Ivars, David, Oliver, Isabel, Tormos, Carmen, Egea, Mercedes, Miguel, Amparo, Sáez, Guillermo T., Carbonell, Félix
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4099055/ https://www.ncbi.nlm.nih.gov/pubmed/25054143 http://dx.doi.org/10.1155/2014/686392

Ejemplares similares

Vascular Endothelial Growth Factor A (VEGFA) Gene Polymorphisms Have an Impact on Survival in a Subgroup of Indolent Patients with Chronic Lymphocytic Leukemia
por: Lozano-Santos, Carol, et al.
Publicado: (2014)

Cytogenetics in Chronic Lymphocytic Leukemia: ERIC Perspectives and Recommendations
por: Baliakas, Panagiotis, et al.
Publicado: (2022)

Action of chronic irradiation on the cytogenetic damage of human lymphocyte culture.
por: Zaichkina, S I, et al.
Publicado: (1997)

Identification of a cytogenetic and molecular subgroup of acute myeloid leukemias showing sensitivity to L-Asparaginase
por: Bertuccio, Salvatore Nicola, et al.
Publicado: (2017)

Cytogenetic and Molecular Predictors of Outcome in Acute Lymphocytic Leukemia: Recent Developments
por: Iacobucci, Ilaria, et al.
Publicado: (2012)

Smoking and the risk of acute myeloid leukaemia in cytogenetic subgroups
por: Moorman, A V, et al.
Publicado: (2002)

Evaluation of MLPA as a comprehensive molecular cytogenetic tool to detect cytogenetic markers of chronic lymphocytic leukemia in Egyptian patients
por: Eid, Ola M., et al.
Publicado: (2021)

Mitogen-activated protein kinase binding protein 1 (MAPKBP1) is an unfavorable prognostic biomarker in cytogenetically normal acute myeloid leukemia
por: Fu, Lin, et al.
Publicado: (2015)

Presence of serum antinuclear antibodies correlating unfavorable overall survival in patients with chronic lymphocytic leukemia
por: Sun, Qian, et al.
Publicado: (2019)

Cytogenetic/mutation profile of chronic lymphocytic leukemia/malignant melanoma collision tumors of the skin
por: La Starza, Roberta, et al.
Publicado: (2018)

Optical Genome Mapping as an Alternative to FISH-Based Cytogenetic Assessment in Chronic Lymphocytic Leukemia
por: Valkama, Andriana, et al.
Publicado: (2023)

ZAP70 Expression Within del6q21, del11q13 and del17p13 Cytogenetic Subgroups of Iranian Patients with Chronic Lymphocytic Leukemia
por: Jafari Ghahfarokhi, Hamideh, et al.
Publicado: (2014)

MYD88 mutations predict unfavorable prognosis in Chronic Lymphocytic Leukemia patients with mutated IGHV gene
por: Qin, Shu-Chao, et al.
Publicado: (2017)

Prognostic significance of translocations in the presence of mutated IGHV and of cytogenetic complexity at diagnosis of chronic lymphocytic leukemia
por: Heerema, Nyla A., et al.
Publicado: (2020)

PB2027: EFFICACY OF THERAPY IN PATIENTS WITH NEWLY DIAGNOSED MYELODYSPLASTIC SYNDROME WITH UNFAVORABLE IMMUNOPHENOTYPIC AND CYTOGENETIC PROGNOSIS.
por: Trubkina, Hanna, et al.
Publicado: (2023)

Subgroup-specific gene expression profiles and mixed epistasis in chronic lymphocytic leukemia
por: Lütge, Almut, et al.
Publicado: (2023)

MYC amplification in leukemia detected by cytogenetics
por: Safranauskas, Roberta Maria da Silva Oliveira, et al.
Publicado: (2021)

Genetic and Histopathological Heterogeneity of Neuroblastoma and Precision Therapeutic Approaches for Extremely Unfavorable Histology Subgroups
por: Shimada, Hiroyuki, et al.
Publicado: (2022)

Expression levels of HMGA2 in adipocytic tumors correlate with morphologic and cytogenetic subgroups
por: Bartuma, Hammurabi, et al.
Publicado: (2009)

Relevance of Stereotyped B-Cell Receptors in the Context of the Molecular, Cytogenetic and Clinical Features of Chronic Lymphocytic Leukemia
por: Maura, Francesco, et al.
Publicado: (2011)

Chronic Lymphocytic Leukemia with t(14;18)(q32;q21) As a Sole Cytogenetic Abnormality
por: Elyamany, Ghaleb, et al.
Publicado: (2014)

Altered expression of MALAT1 lncRNA in chronic lymphocytic leukemia patients, correlation with cytogenetic findings
por: Ahmadi, Abdolrahim, et al.
Publicado: (2018)

Duplication of 8q24 in Chronic Lymphocytic Leukemia: Cytogenetic and Molecular Biologic Analysis of MYC Aberrations
por: Ondroušková, Eva, et al.
Publicado: (2022)

P615: GENE-GENE INTERACTIONS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA WITH VARIOUS CYTOGENETIC PROGNOSTIC FACTORS
por: Nazarova, Elena, et al.
Publicado: (2023)

Cytogenetic studies in lymphocytes of patients with rectal cancer.
por: Gebhart, E, et al.
Publicado: (1993)

Cytogenetic effects of heavy ions in human lymphocytes
por: Krasavin, E A, et al.
Publicado: (1997)

MUM1/IRF4 Expression Is an Unfavorable Prognostic Factor in B‐Cell Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
por: Ito, Masato, et al.
Publicado: (2002)

Cluster Analysis of Clinical Data Identifies Fibromyalgia Subgroups
por: Docampo, Elisa, et al.
Publicado: (2013)

Modern treatment in chronic lymphocytic leukemia: impact on survival and efficacy in high-risk subgroups
por: Cuneo, Antonio, et al.
Publicado: (2014)

Multi-platform profiling characterizes molecular subgroups and resistance networks in chronic lymphocytic leukemia
por: Bloehdorn, Johannes, et al.
Publicado: (2021)

Daratumumab, lenalidomide, and dexamethasone in relapsed/refractory myeloma: a cytogenetic subgroup analysis of POLLUX
por: Kaufman, Jonathan L., et al.
Publicado: (2020)

Cytogenetic and molecular abnormalities in chronic myelomonocytic leukemia
por: Patnaik, M M, et al.
Publicado: (2016)

Cytogenetics’ impact on the prognosis of acute myeloid leukemia
por: Gupta, Monika, et al.
Publicado: (2019)

Combined Patterns of IGHV Repertoire and Cytogenetic/Molecular Alterations in Monoclonal B Lymphocytosis versus Chronic Lymphocytic Leukemia
por: Henriques, Ana, et al.
Publicado: (2013)

Cytogenetic Abnormalities with Interphase FISH Method and Clinical Manifestation in Chronic Lymphocytic Leukemia Patients in North-East of Iran
por: Rahimi, Hossein, et al.
Publicado: (2017)

NEAT1 Long Isoform Is Highly Expressed in Chronic Lymphocytic Leukemia Irrespectively of Cytogenetic Groups or Clinical Outcome
por: Ronchetti, Domenica, et al.
Publicado: (2020)

Clinical and Cytogenetic Characterization, and Outcome of Chronic Lymphocytic Leukemia Patients in a Single Tertiary Center in Saudi Arabia
por: Al Mugairi, Areej, et al.
Publicado: (2023)

Dual Negativity of CD56 and CD117 Links to Unfavorable Cytogenetic Abnormalities and Predicts Poor Prognosis in Multiple Myeloma
por: Zheng, Dong, et al.
Publicado: (2022)

Identification of Clinically Relevant Subgroups of Chronic Lymphocytic Leukemia Through Discovery of Abnormal Molecular Pathways
por: Taus, Petr, et al.
Publicado: (2021)

Whole-genome sequencing of chronic lymphocytic leukemia identifies subgroups with distinct biological and clinical features
por: Robbe, Pauline, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_iks4pspuf5rj1m629praeap3tr